tetano
Editor, Senior Moderator
Influenza Other Respir Viruses. 2019 Mar 4. doi: 10.1111/irv.12637. [Epub ahead of print]
[h=1]Community spread and late season increased incidence of oseltamivir-resistant influenza A(H1N1) viruses in Norway 2016.[/h] Bragstad K[SUP]1[/SUP], Hungnes O[SUP]1[/SUP], Litleskare I[SUP]2[/SUP], Nyrer?d HC[SUP]3[/SUP], Dorenberg DH[SUP]1[/SUP], Hauge SH[SUP]1[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] Antiviral resistance in Norwegian influenza viruses is rare. Only one A(H1N1)pdm09 virus from May 2015 had been found resistant to oseltamivir since the introduction of these viruses in 2009.
[h=4]OBJECTIVES:[/h] Surveillance of antiviral resistance is part of the Norwegian surveillance system, to rapidly detect the development of antiviral-resistant viruses and spread in the community. We describe the spread of oseltamivir-resistant A(H1N1)pdm09 viruses in Norway in the 2016-17 season, found as part of the routine surveillance.
[h=4]METHODS:[/h] Influenza H1N1 viruses were analysed for antiviral resistance by pyrosequencing, neuraminidase susceptibility assay and by Sanger sequencing of the HA and NA genes.
[h=4]RESULTS:[/h] During the 2015-16 influenza season, 3% of all A(H1N1)pdm09 viruses screened for resistance in Norway were resistant to oseltamivir, possessing the H275Y substitution in the neuraminidase protein. In comparison, the overall frequency in Europe was 0.87%. Out of these, 37% (n = 10) were reported from Norway. Most cases in Norway were not related to antiviral treatment, and the cases were from several different locations of southern Norway. Genetic analysis revealed that resistant virus emerged independently on several occasions and that there was some spread of oseltamivir-resistant influenza A(H1N1)6B.1 viruses in the community, characterised by a N370S substitution in the haemagglutinin and T48I in the neuraminidase.
[h=4]CONCLUSIONS:[/h] Our findings emphasise the importance of antiviral resistance surveillance in the community, not only in immunocompromised patients or other patients undergoing antiviral treatment.
? 2019 The Authors. Influenza and Other Respiratory Viruses Published by John Wiley & Sons Ltd.
[h=4]KEYWORDS:[/h] H275Y; antiviral resistance; influenza; surveillance
PMID: 30834715 DOI: 10.1111/irv.12637
Free full text
[h=1]Community spread and late season increased incidence of oseltamivir-resistant influenza A(H1N1) viruses in Norway 2016.[/h] Bragstad K[SUP]1[/SUP], Hungnes O[SUP]1[/SUP], Litleskare I[SUP]2[/SUP], Nyrer?d HC[SUP]3[/SUP], Dorenberg DH[SUP]1[/SUP], Hauge SH[SUP]1[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] Antiviral resistance in Norwegian influenza viruses is rare. Only one A(H1N1)pdm09 virus from May 2015 had been found resistant to oseltamivir since the introduction of these viruses in 2009.
[h=4]OBJECTIVES:[/h] Surveillance of antiviral resistance is part of the Norwegian surveillance system, to rapidly detect the development of antiviral-resistant viruses and spread in the community. We describe the spread of oseltamivir-resistant A(H1N1)pdm09 viruses in Norway in the 2016-17 season, found as part of the routine surveillance.
[h=4]METHODS:[/h] Influenza H1N1 viruses were analysed for antiviral resistance by pyrosequencing, neuraminidase susceptibility assay and by Sanger sequencing of the HA and NA genes.
[h=4]RESULTS:[/h] During the 2015-16 influenza season, 3% of all A(H1N1)pdm09 viruses screened for resistance in Norway were resistant to oseltamivir, possessing the H275Y substitution in the neuraminidase protein. In comparison, the overall frequency in Europe was 0.87%. Out of these, 37% (n = 10) were reported from Norway. Most cases in Norway were not related to antiviral treatment, and the cases were from several different locations of southern Norway. Genetic analysis revealed that resistant virus emerged independently on several occasions and that there was some spread of oseltamivir-resistant influenza A(H1N1)6B.1 viruses in the community, characterised by a N370S substitution in the haemagglutinin and T48I in the neuraminidase.
[h=4]CONCLUSIONS:[/h] Our findings emphasise the importance of antiviral resistance surveillance in the community, not only in immunocompromised patients or other patients undergoing antiviral treatment.
? 2019 The Authors. Influenza and Other Respiratory Viruses Published by John Wiley & Sons Ltd.
[h=4]KEYWORDS:[/h] H275Y; antiviral resistance; influenza; surveillance
PMID: 30834715 DOI: 10.1111/irv.12637
Free full text